Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor
Clinical trial NCT01001221 · TERMINATED
Trial details
- NCT number
- NCT01001221
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-10-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.